Riboflavin 5'-Phosphate Sodium.

Pyridoxine 5-phosphate oxidase is a flavoprotein that uses FMN, the coenzyme riboflavin 5-phosphate supplies directly. Without adequate flavin, conversion of dietary B6 forms into the active pyridoxal 5-phosphate slows.

Pyridoxine must be oxidised to pyridoxal 5-phosphate by an FMN-requiring enzyme. Flavin sufficiency is what lets ordinary pyridoxine become the coenzyme form used in amino acid metabolism.

Folate entering the one-carbon cycle passes through the FAD-dependent methylenetetrahydrofolate reductase step before it can donate a methyl group. Riboflavin holds that enzyme in its active flavin-bound state.

Methionine synthase reductase uses FAD and FMN to re-reduce the cobalamin cofactor after it oxidises. Riboflavin keeps that reductase working so B12-dependent methylation continues.

Cobalamin coenzymes are periodically re-activated by a flavin-containing reductase. Adequate riboflavin is what allows B12 to keep cycling rather than sitting oxidised.

Betaine remethylates homocysteine through BHMT while riboflavin supports the folate-dependent MTHFR route to the same product. The two cover different halves of one remethylation demand, and riboflavin also supports the flavoprotein that oxidises choline to betaine.

Choline dehydrogenase is a flavoprotein that converts choline to betaine aldehyde on the way to betaine. Riboflavin supplies the FAD that step depends on.

Glutathione reductase is an FAD flavoprotein that converts oxidised glutathione back to its reduced form. Riboflavin status sets how fast that recycling can run.

NAC supplies cysteine for new glutathione synthesis while riboflavin keeps the FAD-dependent reductase that regenerates existing glutathione. One adds to the pool, the other keeps the pool in its usable reduced state.

Selenium-dependent glutathione peroxidase consumes reduced glutathione, and the FAD-dependent glutathione reductase that riboflavin supports restores it. Both halves of the cycle are needed for either to keep turning over.

Dihydrolipoamide dehydrogenase, the E3 component that re-oxidises lipoamide in the pyruvate and ketoglutarate complexes, is an FAD flavoprotein. Lipoic acid and riboflavin sit on consecutive steps of the same electron relay.

Pyruvate and alpha-ketoglutarate dehydrogenase both require thiamine pyrophosphate at the first step and FAD at the E3 step. A shortfall in either vitamin stalls the same complex.

Pantothenic acid becomes coenzyme A, the acyl carrier for the same dehydrogenase complexes that hand electrons to FAD. The two vitamins serve adjacent roles in carbohydrate and fatty acid oxidation.

Complex I of the respiratory chain holds FMN and accepts electrons from NADH, so the flavin is the direct handover point for NAD-linked reactions. Riboflavin supplies that flavin.

Kynurenine mono-oxygenase, an FAD enzyme, sits on the route from tryptophan to nicotinic acid and then NAD. Riboflavin status governs how much niacin the body can make from tryptophan.

The kynurenine route that takes tryptophan toward NAD passes through a flavin-dependent mono-oxygenase. Low riboflavin diverts tryptophan away from that endpoint.

Succinate dehydrogenase carries covalently bound FAD and passes its electrons straight to the coenzyme Q pool. Flavin sufficiency and Q availability act on consecutive links of the same chain.

Carnitine carries long-chain fatty acids into mitochondria, where every acyl-CoA dehydrogenase step uses FAD and passes electrons through electron transfer flavoprotein. Riboflavin supplies the flavins for the steps carnitine feeds.

Xanthine oxidoreductase and aldehyde oxidase each hold both a molybdenum cofactor and FAD in the same protein. Both the mineral and the flavin are needed for these enzymes to complete an electron transfer.

Human riboflavin kinase, the enzyme that phosphorylates riboflavin to FMN, binds zinc at its active site. Zinc status therefore affects how well dietary riboflavin becomes coenzyme.

FAD synthetase attaches an adenylyl group from ATP to FMN and requires magnesium to do it. Magnesium availability is part of converting riboflavin into the FAD form most flavoproteins use.

Flavin-dependent reductases take part in releasing iron from ferritin and in reducing dietary iron for gut uptake. In people low in riboflavin, supplying both together moves iron status markers more than iron alone.

The enzyme that produces 5-methyltetrahydrofolate holds FAD tightly at its active site, and FAD is made from riboflavin after the phosphate ester is cleaved and re-added in tissue. Poor riboflavin status therefore lowers the throughput of the step that generates the circulating folate form. Supplying the methylated folate directly sidesteps that step, so the two act on the same pathway from different points. This is cofactor biochemistry rather than a tested combination.

S-adenosylmethionine is regenerated from methionine, and methionine is remethylated using the folate form produced by a flavin-dependent enzyme. Riboflavin status therefore sets part of the ceiling on how fast that loop turns. Supplemental SAM-e enters the cycle downstream of the flavoprotein step. The link is mechanistic and drawn from settled biochemistry, not from a combination trial.

Reactivation of methionine synthase depends on a reductase that carries both FAD and FMN, the two coenzyme forms riboflavin becomes. Methionine remethylation slows when flavin supply is short. Pairing dietary methionine with adequate riboflavin keeps the reactivation step supplied rather than adding two independent effects.

Alpha-tocopherol radical is returned to its reduced form largely at the expense of ascorbate and glutathione, and glutathione is regenerated by an FAD-dependent reductase. Riboflavin supply therefore sits behind the whole chain rather than acting as an antioxidant itself. Erythrocyte glutathione reductase activation is in fact the classical laboratory marker of riboflavin status, which is a marker of the vitamin and not an outcome.

Cysteine supplies the thiol that glutathione is built from, while riboflavin supplies the cofactor for the enzyme that keeps that glutathione reduced. One provides material and the other provides turnover. The pairing is drawn from the pathway map rather than from a co-administration study.

Mitochondrial superoxide dismutase is a manganese metalloenzyme and its product, hydrogen peroxide, is handled downstream by glutathione peroxidase working with FAD-dependent glutathione reductase. The two nutrients sit at consecutive stations of the same handling sequence. This is pathway logic, and no combination trial is being cited for it.

Copper is structural in cytosolic superoxide dismutase, whose product is cleared by peroxidase and flavin-dependent reductase steps. Riboflavin sits behind the reductase half of that sequence. Read it as mechanistic complementarity rather than a measured additive effect.

Under light, flavins move to an excited state and generate singlet oxygen and superoxide, which oxidise ascorbate in the same container. Clear liquid formats holding both lose ascorbate faster than the same liquid in opaque packaging. This is a stability interaction in the bottle rather than an interaction in the body, and amber or opaque packaging is the ordinary answer to it.